drugset / Trial / NCT04100642
A Phase I Clinical Study of Hemay808
RandomizedSequentialTriple-blindTreatment
Summary
This is a first-in-human study in health volunteers. The purpose is the local tolerability and systemic safety of Hemay808, which is an ointment made of a novel small molecule Hemay028. The safety and systemic pharmacokinetics (PK) of Hemay028 will be evaluated following topical application of Hemay808 to healthy volunteers.
Timeline
- Start
- 2019-04-08
- Primary completion
- 2019-10-23
- Completion
- 2019-12-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hemay028 | Small molecule | 1 % | Topical |
| Subject | Hemay028 | Small molecule | 3 % | Topical |
| Subject | Hemay028 | Small molecule | 7 % | Topical |
Indications
No indication recorded.